ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Daschle Nomination For HHS Secretary Held Up in Senate Finance Committee; Corr Nominated Deputy HHS Secretary

January 16, 2009

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

In Brief: Pinedo To Receive Josef Steiner Prize; Lurie Cancer Center Gets $2.5M Donation

October 27, 1995

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992